1. INDICATIONS AND USAGE Celecoxib is indicated Celecoxib is a nonsteroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) Rheumatoid Arthritis (RA) Juvenile Rheumatoid Arthritis (JRA) in patients 2 years and older Ankylosing Spondylitis (AS) Acute Pain (AP) Primary Dysmenorrhea (PD) 1.1 Osteoarthritis (OA) For the management of the signs and symptoms of OA. 1.2 Rheumatoid Arthritis (RA) For the management of the signs and symptoms of RA. 1.3 Juvenile Rheumatoid Arthritis (JRA) For the management of the signs and symptoms of JRA in patients 2 years and older. 1.4 Ankylosing Spondylitis (AS) For the management of the signs and symptoms of AS. 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 23, 2018 | Original application | Approved | None posted |
| Sep 29, 2026 | Supplement 5Labeling · Standard review | Approved | None posted |
| Sep 15, 2022 | Supplement 1Labeling · Standard review | Approved | None posted |
| Sep 15, 2022 | Supplement 3Labeling · Standard review | Approved | None posted |
| Sep 15, 2022 | Supplement 4Labeling · Standard review | Approved | None posted |
| Jan 23, 2018 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters